Share Prices & Company Research

Stockbroking

Genus

Current Price 2132.00p Bid 2122.00p Ask 2174.00p Change 0.99%
Last Updated: 22/09/2026 01:12. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Genus plc is a United Kingdom-based animal genetics company. It supplies breeding animals with desirable characteristics to farmers, enabling them to produce quality meat and milk. The Company's segments include Genus PIC, Genus ABS and Genus Research and Development. The Genus PIC segment is engaged in porcine sales business. The Genus ABS segment is engaged in bovine sales business. Its bovine genetics business sells dairy and beef bull semen and embryos from its superior cattle, which are sold to farmers to breed their cows through artificial insemination. Its porcine genetics business sells genetically superior breeding pigs and semen to farmers, so they can breed commercial pigs with desirable characteristics for pork production. It also provides technical services and advice to farmers, to maximize the performance of its breeding animals in their farms.

Financial Highlights Year Ended 30/06/2026

Revenue
£658.10m
Operating Profit/Loss
£87.30m
Dividend yield (%)
1.60
Total dividend for year
n/ap
Dividend cover
3.13
P/E Ratio
19.50

Key Personnel

Mr Jorgen Kokke
Chief Executive Officer
Mr Andy Russell
Chief Financial Officer
Mr Iain Ferguson
Independent Non-Executive Director
Dr Ralph Heuser
Non-Executive Director
Dr Robert Reiter
Non-Executive Director
Mrs Lesley Knox
Non-Executive Director
Ms Celia Baxter
Non-Executive Director
Ms Lysanne Gray
Non-Executive Director

Stock Details

EPIC
GNSL
ISIN
GB0002074580
Shares in Issue
61.00m
Market cap
£1,300.48m

Analyst Views (1)

Strong Buy
 
0%
Buy
 
100.00%
Hold
 
0%
Sell
 
0%
Strong Sell
 
0%
This information is provided by Web Financial Group (UK) Limited. It is subject to change without notice and doesn't reflect the views held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
2,132.00p
Bid Price
2,122.00p
Ask Price
2,174.00p
Volume
22,064
Change Today
21.00p
% Change Today
0.99%
Open
2,118.00p
Previous Close
2,132.00p
Intraday High
2,148.00p
Intraday Low
2,106.00p
52 Week High
3,172.50p
52 Week Low
1,987.00p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Income Statement

Year End Date
30 Jun 2026
30 Jun 2025
 
£ (M)
£ (M)
Continuing Operations
Revenue
658.10
672.80
Operating Profit/Loss
87.30
42.40
Net Interest
-15.80
-18.80
Pre-Tax Profit
310.50
28.50
Profit After Tax from continuing operations
285.50
19.30
Discontinued Operations
Profit After Tax
n/a
n/a
Profit/Loss for the Year
285.50
19.30
Attributable to:
Equity Holders of Parent Company
285.30
19.00
Minority Interests
0.20
n/a
Total Dividend Paid
n/ap
n/ap
Retained Profit/(Loss) for the Financial Year
n/a
n/a

Earnings per Share

Year End Date
30 Jun 2026
30 Jun 2025
Basic
431.60p
29.30p
Diluted
425.10p
28.90p
Adjusted
110.30p
81.80p
Dividend per Share
n/ap
n/ap

Assets

Year End Date
30 Jun 2026
30 Jun 2025
 
£ (M)
£ (M)
Non-Current Assets
Property, Plant & Equipment
353.90
379.30
Intangible Assets
152.90
158.10
Investment Properties
n/a
n/a
Investments
208.60
66.00
Other Financial Assets
n/a
n/a
Other Non-Current Assets
43.30
41.20
Current Assets
Inventories
47.80
46.20
Trade & Other Receivables
120.90
119.20
Cash at Bank & In Hand
43.70
48.00
Current Asset Investments
n/a
n/a
Other Current Assets
47.20
41.00
Other Assets
n/a
n/a
Total Assets
1,018.30
899.00

Liabilities

Year End Date
30 Jun 2026
30 Jun 2025
 
£ (M)
£ (M)
Current Liabilities
Borrowings
4.30
2.90
Other Current Liabilities
112.90
128.40
Total Current Liabilities
117.20
131.30
Non-Current Liabilities
Borrowings
93.40
249.70
Provisions
27.50
26.10
Other Non-Current Liabilities
13.50
15.90
Total Non-Current Liabilities
134.40
291.70
Other Liabilities
n/a
n/a
Total Liabilities
251.60
423.00

Net Assets

Year End Date
30 Jun 2026
30 Jun 2025
 
£ (M)
£ (M)
Net Assets
766.70
476.00

Capital & Reserves

Year End Date
30 Jun 2026
30 Jun 2025
 
£ (M)
£ (M)
Share Capital
6.70
6.60
Share Premium Account
179.10
179.10
Other Reserves
-13.00
-31.20
Retained Earnings
593.90
321.60
Shareholders Funds
766.70
476.10
Minority Interests/Other Equity
n/a
-0.10
Total Equity
766.70
476.00

Dividend History

Type
Ex-Dividend Date
Payment Date
Payment
Final
12 Nov 2026
04 Dec 2026
24.00p
Interim
05 Mar 2026
27 Mar 2026
11.20p
Final
06 Nov 2025
05 Dec 2025
21.70p
Interim
06 Mar 2025
04 Apr 2025
10.30p
Interim
06 Mar 2025
04 Apr 2025
10.30p
Final
07 Nov 2024
06 Dec 2024
21.70p
Interim
29 Feb 2024
28 Mar 2024
10.30p
Final
09 Nov 2023
08 Dec 2023
21.70p
Interim
02 Mar 2023
30 Mar 2023
10.30p
Final
17 Nov 2022
09 Dec 2022
21.70p
Interim
03 Mar 2022
31 Mar 2022
10.30p
Final
18 Nov 2021
10 Dec 2021
21.70p
Interim
04 Mar 2021
01 Apr 2021
10.30p
Final
19 Nov 2020
11 Dec 2020
19.70p
Interim
05 Mar 2020
02 Apr 2020
9.40p
Final
07 Nov 2019
29 Nov 2019
18.80p
Interim
07 Mar 2019
04 Apr 2019
8.90p
Final
15 Nov 2018
30 Nov 2018
17.90p
Interim
08 Mar 2018
04 Apr 2018
8.10p
Final
16 Nov 2017
01 Dec 2017
16.20p
Interim
02 Mar 2017
31 Mar 2017
7.40p
Final
17 Nov 2016
02 Dec 2016
14.70p
Interim
03 Mar 2016
30 Mar 2016
6.70p
Final
19 Nov 2015
04 Dec 2015
13.40p
Interim
05 Mar 2015
27 Mar 2015
6.10p
Final
09 Nov 2011
25 Nov 2011
13.30p

Dividend Metrics

Year End Date
30 Jun 2026
30 Jun 2025
Dividend growth
10.00%
n/a%
Dividend yield
1.60%
1.60%
Dividend cover
3.13
2.56


Cboe Global Markets® is a registered trade mark of Cboe Global Markets, Inc., a company incorporated in the United States of America with registered address at 400 South LaSalle Street, Chicago, IL 60605, USA. Cboe shall own any and all rights including without limitation Intellectual Property rights and any and all goodwill arising directly or indirectly out of the Recipient’s use of the “Cboe Global Markets®”, “Cboe®” and “Bats®”” trademarks. Neither Cboe nor its licensors accept any liability for any errors or omissions in the Cboe Europe Indices or underlying data. No further distribution of Cboe Europe data is permitted without Cboe’s express written consent.

The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.